These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 17487237)
1. Modulatory role of verapamil treatment on the cardiac electrophysiological effects of cisapride. Morissette P; Hreiche R; Turgeon J Can J Physiol Pharmacol; 2006 Dec; 84(12):1285-90. PubMed ID: 17487237 [TBL] [Abstract][Full Text] [Related]
2. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Drolet B; Khalifa M; Daleau P; Hamelin BA; Turgeon J Circulation; 1998 Jan; 97(2):204-10. PubMed ID: 9445174 [TBL] [Abstract][Full Text] [Related]
3. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031 [TBL] [Abstract][Full Text] [Related]
4. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential? Carlsson L; Amos GJ; Andersson B; Drews L; Duker G; Wadstedt G J Pharmacol Exp Ther; 1997 Jul; 282(1):220-7. PubMed ID: 9223557 [TBL] [Abstract][Full Text] [Related]
5. Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil. Bova S; Cargnelli G; D'Amato E; Forti S; Yang Q; Trevisi L; Debetto P; Cima L; Luciani S; Padrini R Br J Pharmacol; 1997 Jan; 120(1):19-24. PubMed ID: 9117093 [TBL] [Abstract][Full Text] [Related]
6. Effects of the T-type Ca(2+) channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue. Bénardeau A; Weissenburger J; Hondeghem L; Ertel EA J Pharmacol Exp Ther; 2000 Feb; 292(2):561-75. PubMed ID: 10640293 [TBL] [Abstract][Full Text] [Related]
7. The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential. Gao Z; Milnes JT; Choisy SC; Leach MJ; Hancox JC; James AF Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1088-96. PubMed ID: 16445575 [TBL] [Abstract][Full Text] [Related]
8. Erythromycin potentiates PR interval prolonging effect of verapamil in the rat: a pharmacodynamic drug interaction. Dakhel Y; Jamali F Toxicol Appl Pharmacol; 2006 Jul; 214(1):24-9. PubMed ID: 16466760 [TBL] [Abstract][Full Text] [Related]
9. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists. Zahradníková A; Minarovic I; Zahradník I J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903 [TBL] [Abstract][Full Text] [Related]
10. Isolated perfused and paced guinea pig heart to test for drug-induced changes of the QT interval. Cheng HC; Incardona J; McCullough B J Pharmacol Toxicol Methods; 2006; 54(3):278-87. PubMed ID: 16507347 [TBL] [Abstract][Full Text] [Related]
11. A novel method of selecting human embryonic stem cell-derived cardiomyocyte clusters for assessment of potential to influence QT interval. Yamazaki K; Hihara T; Taniguchi T; Kohmura N; Yoshinaga T; Ito M; Sawada K Toxicol In Vitro; 2012 Mar; 26(2):335-42. PubMed ID: 22198052 [TBL] [Abstract][Full Text] [Related]
12. An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts. Wu L; Shryock JC; Song Y; Belardinelli L J Pharmacol Exp Ther; 2006 Feb; 316(2):718-26. PubMed ID: 16234410 [TBL] [Abstract][Full Text] [Related]
13. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation. Takahara A; Sugiyama A; Hashimoto K Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235 [TBL] [Abstract][Full Text] [Related]
14. Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring. Sugiyama A; Hashimoto K Toxicol Appl Pharmacol; 1998 Sep; 152(1):261-9. PubMed ID: 9772221 [TBL] [Abstract][Full Text] [Related]
16. Effects of cisapride on ventricular repolarization in children. Tutar HE; Kansu A; Kalayci AG; Girgin N; Atalay S; Imamoğlu A Acta Paediatr; 2000 Jul; 89(7):820-3. PubMed ID: 10943965 [TBL] [Abstract][Full Text] [Related]
17. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of gallopamil and verapamil on the mechanical and electrophysiological parameters of isolated guinea-pig myocardium. Noguchi K; Masumiya H; Takahashi K; Kaneko K; Higuchi S; Tanaka H; Shigenobu K Can J Physiol Pharmacol; 1997 Dec; 75(12):1316-21. PubMed ID: 9534940 [TBL] [Abstract][Full Text] [Related]
19. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart. Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428 [TBL] [Abstract][Full Text] [Related]
20. The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome. Schwoerer AP; Kebernik J; Ehmke H; Friederich P Anesth Analg; 2010 Sep; 111(3):638-46. PubMed ID: 20601449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]